Archives

by in
Entry Author Date Location
Alnylam Eyes RNAi for Manufacturing Drugs 11/12/09 Boston
Synageva Finishes $45M Round 10/20/09 Boston
New England Firms Poised for Biogeneric Future, Tobin Bids Boston Scientific Adieu, Biogen Idec Reports Tenth PML Case, & More Boston-Area Life Sciences News 07/01/09 Boston
Biogen and Fellow Boston-Area Biotechs Ready for Biogenerics 06/24/09 Boston
FDA Decision a Blow For Genzyme—and Biogenerics? 04/22/08 Boston
GTC Biotherapeutics, Racing Against Time to Prove the Worth of “Pharming” 02/11/08 Boston
Setback for Momenta, Setback for Biogenerics? 11/08/07 Boston
The State of Biotechnology, According to Biogen Idec CEO Jim Mullen 08/16/07 Boston
Genzyme’s Myozyme Production Problems Fuel Online Biogenerics Debate 08/10/07 Boston
Page 1 of 1

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  2. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Zillions of Biotech Conferences Want You. Which Should You Attend?
  5. Announcing Xconomy Napa Summit 2013: New Rules for Growth

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.